Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trial

Marcelo Augusto Duarte Silveira(D’Or Institute for Research and Education), Rogério da Hora Passos(Yahoo (Spain)), Erica Batista dos Santos Galvão(D’Or Institute for Research and Education), Suzete Nascimento Farias da Guarda(Universidade Federal da Bahia), Marcel Miranda Dantas Gomes(D’Or Institute for Research and Education), Juliana Caldas(Escola Bahiana de Medicina e Saúde Pública), Cicero Wandson Luiz Macedo De Oliveira(D’Or Institute for Research and Education), Andresa Aparecida Berretta(Universidade de São Paulo), Lucas Petri Damiani(Hospital Israelita Albert Einstein), Rodrigo Morel Vieira de Melo(Universidade Federal da Bahia), Maurício Brito Teixeira(Universidade do Estado da Bahia), Flávia Mendes Leite(D’Or Institute for Research and Education), Bruno Andrade Bahiense(D’Or Institute for Research and Education), Milena Souza Alves(D’Or Institute for Research and Education), Nathália Ursoli Baptista(Apis Flora (Brazil)), Talita Rocha Mascarenhas(D’Or Institute for Research and Education), Sérgio Pinto de Souza(Escola Bahiana de Medicina e Saúde Pública), Carolina Kymie Vasques Nonaka(D’Or Institute for Research and Education), Bruno Solano de Freitas Souza(D’Or Institute for Research and Education), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Matheus de Alencar Menezes(D’Or Institute for Research and Education), Flávio Teles(Universidade Federal de Alagoas), Julia Barros Cabral(D’Or Institute for Research and Education), Priscila Pinheiro(D’Or Institute for Research and Education)
Scientific Reports
October 27, 2023
10.1038/s41598-023-43764-w
Cited by 8

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467
Zika virus infection induces mitosis abnormalities and apoptotic cell death of human neural progenitor cells
|Scientific Reports|2016|216
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
|Emerging infectious diseases|2021|215